Influence of long-term antibiotic therapy on gut microbiome composition and metabolic profile in pulmonary tuberculosis
- Authors: Yunusbaeva M.M.1, Terentyeva D.R.1,2, Borodina L.Y.3, Zakirova A.M.3, Bulatov S.E.3, Bilalov F.S.3,4, Yunusbayev B.B.5
-
Affiliations:
- ITMO University
- Pasteur Institute
- Republican Clinical Antituberculous Dispensary
- Bashkir State Medical University
- St. Petersburg State University
- Issue: Vol 13, No 6 (2023)
- Pages: 1079-1088
- Section: ORIGINAL ARTICLES
- URL: https://journals.rcsi.science/2220-7619/article/view/252308
- DOI: https://doi.org/10.15789/2220-7619-IOL-16867
- ID: 252308
Cite item
Full Text
Abstract
The use of long-term multicomponent antibiotic therapy is the most effective way to treat tuberculosis (TB). However, little is known about the effect of this chemotherapy on the human intestinal microflora. The purpose of this study was to analyze an effect of long-term antibiotic therapy on gut microbiome composition and metabolic profile in TB patients. We used deep sequencing of fecal samples from 23 treatment-naive TB patients to reconstruct the metabolic capacity and strain/species-level abundance in the gut microbiome. Two fecal samples were obtained from each patient: before and after treatment. We showed that TB treatment regimen does not disrupt the overall diversity of the gut microbiome but does have an impact on gut bacterial microbiome composition and metabolic profile. While taking first-line anti-tuberculosis drugs (isoniazid, rifampicin, ethambutol, pyrazinamide), TB patients showed an apparent increase in Actinobacteria abundance. Pairwise comparison of metagenomic data revealed 28 differentially represented bacterial taxa, of which three species Bacteroides cellulosilyticus, Enterocloster aldensis, Clostridium spiroforme were strongly enriched in TB patients post-chemotherapy, whereas 25 species were enriched in TB patients before treatment (Bifidobacterium catenulatum, Enterococcus faecium, Bacteroides salyersiae, Bacteroides xylanisolvens, Bacteroides eggerthii, Lachnospira eligens, Akkermansia muciniphila, Ruminococcus lactaris, etc.) (p < 0.05). The metabolic profile of the gut microbiome was characterized by increased metabolic processes aimed at the growth and division of microbial cells. Iron is the main limiting factor for growth and reproduction. In addition, it is important to note the prevalence of glycolysis and lactate fermentation as the major means for energy production by intestinal microbiota.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Milyausha M. Yunusbaeva
ITMO University
Author for correspondence.
Email: milyausha_ufa@mail.ru
PhD (Biology), Senior Researcher, ChemBio Cluster
Russian Federation, Saint-PetersburgD. R. Terentyeva
ITMO University; Pasteur Institute
Email: milyausha_ufa@mail.ru
Engineer, ChemBio Cluster; Junior Researcher, Laboratory of Molecular Epidemiology and Evolutionary Genetics
Russian Federation, Saint-Petersburg; Saint-PetersburgL. Ya. Borodina
Republican Clinical Antituberculous Dispensary
Email: milyausha_ufa@mail.ru
Phthisiologist, Deputy Chief Physician for Organizational and Methodological Work
Russian Federation, UfaA. M. Zakirova
Republican Clinical Antituberculous Dispensary
Email: milyausha_ufa@mail.ru
Head of the Tuberculosis Monitoring Office
Russian Federation, UfaS. E. Bulatov
Republican Clinical Antituberculous Dispensary
Email: milyausha_ufa@mail.ru
PhD (Medicine), Head Physician
Russian Federation, UfaF. S. Bilalov
Republican Clinical Antituberculous Dispensary; Bashkir State Medical University
Email: milyausha_ufa@mail.ru
DSc (Medicine), Head Physician; Assistant Professor, Department of Laboratory Diagnostics
Russian Federation, Ufa; UfaB. B. Yunusbayev
St. Petersburg State University
Email: milyausha_ufa@mail.ru
PhD (Biology), Senior Researcher, Associate Professor
Russian Federation, St. PetersburgReferences
- Arrieta M.C., Arevalo A., Stiemsma L., Dimitriu P., Chico M.E., Loor S., Vaca M., Boutin R., Morien E., Jin M., Turvey S.E., Walter J., Parfrey L., Cooper P.J., Finlay B. Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting. J. Allergy. Clin. Immunol., 2018, vol. 142, no. 2, pp. 424–434.e10. doi: 10.1016/j.jaci.2017.08.041
- Barka E.A., Vatsa P., Sanchez L., Gaveau-Vaillant N., Jacquard C., Meier-Kolthoff J.P., Klenk H.P., Clement C., Ouhdouch Y., van Wezel G.P. Taxonomy, physiology, and natural products of Actinobacteria. Microbiol. Mol. Biol. Rev., 2015, vol. 80, no. 1, pp. 1–43. doi: 10.1128/MMBR.00019-15
- Blanco-Miguez A., Beghini F., Cumbo F., McIver L.J., Thompson K.N., Zolfo M., Manghi P., Dubois L., Huang K.D., Maltez A.T., Nickols W.A., Piccinno G., Piperni E., Punčochář M., Valles-Colomer M., Tett A., Giordano F., Davies R., Wolf G., Berry S.E., Spector T.D., Franzosa E.A., Pasolli E., Asnicar F., Huttenhower C., Segata N. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat. Biotechnol., 2023. doi: 10.1038/s41587-023-01688-w
- Brennan P.J., Young D.B., Robertson B.D., Andersen P., Barry III C.E., Britton W. Handbook of anti-tuberculosis agents. Introduction. Tuberculosis, 2008, vol. 88, no. 2, pp. 85–86. doi: 10.1016/S1472-9792(08)70002-7
- Burckhardt J.C., Chong D.H.Y., Pett N., Tropini C. Gut commensal Enterocloster species host inoviruses that are secreted in vitro and in vivo. Microbiome, 2023, vol. 11, no. 1: 65. doi: 10.1186/s40168-023-01496-z
- Chen S., Zhou Y., Chen Y., Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics, 2018, vol. 34, no. 17, pp. i884–i890. doi: 10.1093/bioinformatics/bty560
- Elias-Oliveira J., Leite J.A., Pereira I.S., Guimaraes J.B., Manso G.M.D.C., Silva J.S., Tostes R.C., Carlos D. NLR and intestinal dysbiosis-associated inflammatory illness: drivers or dampers? Front. Immunol., 2020, vol. 11: 1810. doi: 10.3389/fimmu.2020.01810
- Esaiassen E., Hjerde E., Cavanagh J.P., Simonsen G.S., Klingenberg C.; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: clinical characteristics and a genomic approach to assess pathogenicity. J. Clin. Microbiol., 2017, vol. 55, no. 7, pp. 2234–2248. doi: 10.1128/JCM.00150-17
- Frankenberg N., Moser J., Jahn D. Bacterial heme biosynthesis and its biotechnological application. Appl. Microbiol. Biotechnol., 2003, vol. 63, no. 2, pp. 115–127. doi: 10.1007/s00253-003-1432-2
- Gueimonde M., Arboleya S. Resistance of Bifidobacteria toward antibiotics. Methods Mol. Biol., 2021, vol. 2278, pp. 195–208. doi: 10.1007/978-1-0716-1274-3_16
- Guo P., Zhang K., Ma X., He P. Clostridium species as probiotics: potentials and challenges. J. Anim. Sci. Biotechnol., 2020, vol. 11: 24. doi: 10.1186/s40104-019-0402-1
- Hu Y., Yang Q., Liu B., Dong J., Sun L., Zhu Y., Su H., Yang J., Yang F., Chen X., Jin Q. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs. J. Infect., 2019, vol. 78, no. 2, pp. 317–322. doi: 10.1016/j.jinf.2018.08.006
- Kamada N., Chen G.Y., Inohara N., Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol., 2013, vol. 14, no. 7, pp. 685–690. doi: 10.1038/ni.2608
- Korten V., Murray B.E. Impact of the fluoroquinolones on gastrointestinal flora. Drugs, 1993, vol. 45, suppl. 3, pp. 125–133. doi: 10.2165/00003495-199300453-00021
- Mai-Prochnow A., Hui J.G.K., Kjelleberg S., Rakonjac J., McDougald D., Rice S.A. Big things in small packages: the genetics of filamentous phage and effects on fitness of their host. FEMS Microbiol. Rev., 2015, vol. 39, no. 4, pp. 465–487. doi: 10.1093/femsre/fuu007
- Namasivayam S., Maiga M., Yuan W., Thovarai V., Costa D.L., Mittereder L.R., Wipperman M.F., Glickman M.S., Dzutsev A., Trinchieri G., Sher A. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome, 2017, vol. 5, no. 1: 71. doi: 10.1186/s40168-017-0286-2
- Saarela M., Matto J., Mattila-Sandholm T. Safety aspects of Lactobacillus and Bifidobacterium species originating from human oro-gastrointestinal tract or from probiotic products. Microb. Ecol. Health. Dis., 2002, vol. 14, no. 4, pp. 234–241. doi: 10.1080/08910600310002127
- Schaechter M. Encyclopedia of Microbiology (3rd ed.). Oxford, San Diego: Academic Press, 2009. 4600 p.
- Seishima J., Iida N., Kitamura K., Yutani M., Wang Z., Seki A., Yamashita T., Sakai Y., Honda M., Yamashita T., Kagaya T., Shirota Y., Fujinaga Y., Mizukoshi E., Kaneko S. Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host. Genome Biol., 2019, vol. 20, no. 1: 252. doi: 10.1186/s13059-019-1879-9
- Suzek B.E., Wang Y., Huang H., McGarvey P.B., Wu C.H., UniProt Consortium. UniRef clusters: a comprehensive and scalable alternative for improving sequence similarity searches. Bioinformatics, 2015, vol. 31, no. 6, pp. 926–932. doi: 10.1093/bioinformatics/btu739
- Trompette A., Gollwitzer E.S., Yadava K., Sichelstiel A.K., Sprenger N., Ngom-Bru C., Blanchard C., Junt T., Nicod L.P., Harris N.L., Marsland B.J. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med., 2014, vol. 20, no. 2, pp. 159–166. doi: 10.1038/nm.3444
- Uzal F.A., Navarro M.A., Li J., Freedman J.C., Shrestha A., McClane B.A. Comparative pathogenesis of enteric clostridial infections in humans and animals. Anaerobe, 2018, vol. 53, pp. 11–20. doi: 10.1016/j.anaerobe.2018.06.002
- Veloo A.C.M., Baas W.H., Haan F.J., Coco J., Rossen J.W. Prevalence of antimicrobial resistance genes in Bacteroides spp. and Prevotella spp. Dutch clinical isolates. Clin. Microbiol. Infect., 2019, vol. 25, no. 9, pp. 1156.e9–1156.e13. doi: 10.1016/j.cmi.2019.02.017
- Warren Y.A., Tyrrell K.L., Citron D.M., Goldstein E.J.C. Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections. J. Clin. Microbiol., 2006, vol. 44, no. 7, pp. 2416–2422. doi: 10.1128/JCM.00116-06
- Wexler H.M. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev., 2007, vol. 20, no. 4, pp. 593–621. doi: 10.1128/cmr.00008-07
- Wingett S.W., Andrews S. FastQ Screen: a tool for multi-genome mapping and quality control. F1000Research, 2018, vol. 7: 1338. doi: 10.12688/f1000research.15931.2
- Wipperman M.F., Fitzgerald D.W., Juste M.A.J., Taur Y., Namasivayam S., Sher A., Bean J.M., Bucci V., Glickman M.S. Antibiotic treatment for tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Sci. Rep., 2017, vol. 7, no. 1: 10767. doi: 10.1038/s41598-017-10346-6
- Wolfe A.J. Glycolysis for microbiome generation. Microbiol. Spectr., 2015, vol. 3, no. 3: 10.1128/microbiolspec.MBP-0014-2014. doi: 10.1128/microbiolspec.MBP-0014-2014
Supplementary files
